Psyence Biomedical Ltd. (PBM)
NASDAQ
$5.60−$0.2600 (−4.44%) on the dayAs of the close; data may be delayed.
PBM price, last 12 months
Key stats
- Previous close
- $5.86
- Open
- $5.91
- Day range
- $5.41 – $5.96
- 52-week range
- $1.92 – $28.13
- Volume
- 96.7K
- Avg volume (20 days)
- 91.6K
- Market cap
- $21.2M
Performance
1W−15.5%
1M+29.6%
3M+88.6%
6M+112.9%
YTD+18.9%
1Y−75.2%
vs S&P 500, 1Y−92.0 pts
Technicals and fundamentals
About Psyence Biomedical Ltd.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
- Listed on
- NASDAQ
- Market cap
- $21.2M